Last 4,197 GBp
Change Today +33.00 / 0.79%
Volume 601.0K
SHP On Other Exchanges
Symbol
Exchange
SHP is not on other exchanges.
As of 7:55 AM 10/31/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mario Saltarelli M.D., Ph.D.

Former Senior Vice President of Clinical Development and Medical Affairs, Shire plc
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

54--

Background*

Dr. Mario Saltarelli, M.D., Ph.D. has been the Chief Science Officer and Senior Vice President of Mallinckrodt Plc since October 2013. Dr. Saltarelli served as Senior Vice President of Clinical Development and Medical Affairs at Shire plc since February 2011. His diverse background spans nearly two decades across medical science, clinical drug development, and the scientific and regulatory aspects of clinical program design. He joined Shire from Abbott Laboratories, ...

Read Full Background

Corporate Headquarters*

5 Riverwalk
Dublin, Co. Dublin 24

Ireland

Phone: 353 1 429 7700
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD
Johns Hopkins University
MD
Johns Hopkins University
BS
University of Illinois-Urbana-Champaign

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SHP:LN 4,197.00 GBp +33.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Rajiv Kanishka Liyanaarchchie De Silva Chief Executive Officer, President and Director
Endo International plc
$4.3M
Joseph C. Papa Chairman, Chief Executive Officer and President
Perrigo Company Public Limited Company
$1.1M
Yves L'epine Chief Executive Officer, Director and Member of Strategy & Innovation Committee
Guerbet SA
€370.8K
Arthur P. Bedrosian J.D.Chief Executive Officer, President, Director and Chairman of Strategic Planning Committee
Lannett Company, Inc.
$539.0K
F. Michael Ball Chief Executive Officer, Director and Member of Science & Technology Committee
Hospira Inc.
$1.0M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHIRE PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.